DanielCMathewsMD

PubMed

• 52 citations
  A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression
  Erica M. Richards, Daniel C. Mathews, David A. Luckenbaugh, Dawn F. Ionescu, Rodrigo Machado-Vieira, Mark J. Niciu, Wallace C. Duncan, Neal M. Nolan, Jose A. Franco-Ch...> ;Psychopharmacology. 2016 Jan 4
• 42 citations
  Developing Biomarkers in Mood Disorders Research Through the Use of Rapid-Acting Antidepressants
  Mark J. Niciu, Daniel C. Mathews, Allison C. Nugent, Dawn F. Ionescu, Maura L. Furey, Erica M. Richards, Rodrigo Machado-Vieira, Carlos A. Zarate> ;Depression and Anxiety. 2014 Apr 1
• 8 citations
  Biomarkers in mood disorders research: developing new and improved therapeutics
  Mark J. Niciu, Daniel C. Mathews, Dawn F. Ionescu, Erica M. Richards, Maura L. Furey, Peixiong Yuan, Allison C. Nugent, Ioline D. Henter, Rodrigo Machado-Vieira, Carlo...> ;Revista De Psiquiatria Clinica. 2014 Jan 1
• 27 citations
  Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression
  Mark J. Niciu, David A. Luckenbaugh, Dawn F. Ionescu, Daniel C. Mathews, Erica M. Richards, Carlos A. Zarate> ;Biological Psychiatry. 2013 Nov 15
• 14 citations
  Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.
  Mark J. Niciu, Dawn F. Ionescu, Daniel C. Mathews, Erica M. Richards, Carlos A. Zarate> ;CNS Spectrums. 2013 Oct 1
• 35 citations
  Second messenger/signal transduction pathways in major mood disorders: Moving from membrane to mechanism of action, part I: Major depressive disorder
  Mark J. Niciu, Dawn F. Ionescu, Daniel C. Mathews, Erica M. Richards, Carlos A. Zarate> ;CNS Spectrums. 2013 Oct 1
• 188 citations
  A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
  Carlos A. Zarate, Daniel C. Mathews, Jose Franco Chaves, Craig A. Marquardt, Immaculata Ukoh, Libby Jolkovsky, Nancy E. Brutsche, Mark A. Smith, David A. Luckenbaugh, ...> ;Biological Psychiatry. 2013 Aug 15
• 15 citations
  Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine.
  Mary C. Zeng, Mark J. Niciu, David A. Luckenbaugh, Dawn F. Ionescu, Daniel C. Mathews, Erica M. Richards, Jose A. Franco-Chaves, Nancy E. Brutsche, Carlos A. Zarate> ;Biological Psychiatry. 2013 Jun 15
• 76 citations
  Human biomarkers of rapid antidepressant effects.
  Carlos A. Zarate, Daniel C. Mathews, Maura L. Furey> ;Biological Psychiatry. 2013 Jun 15
• 30 citations
  Neurobiological aspects of suicide and suicide attempts in bipolar disorder
  Daniel C. Mathews, Erica M. Richards, Mark J. Niciu, Dawn F. Ionescu, Joseph J. Rasimas, Carlos A. Zarate> ;Translational Neuroscience. 2013 Jun 9
• 21 citations
  Current Status of Ketamine and Related Compounds for Depression
  Daniel C. Mathews, Carlos A. Zarate> ;The Journal of Clinical Psychiatry. 2013 May 15
• 81 citations
  Neurobiology of anxious depression: a review.
  Dawn F. Ionescu, Mark J. Niciu, Daniel C. Mathews, Erica M. Richards, Carlos A. Zarate> ;Depression and Anxiety. 2013 Apr 1
• 52 citations
  Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
  David A. Luckenbaugh, Nancy E. Brutsche, Jose A. Franco-Chaves, Daniel C. Mathews, Craig A. Marquardt, Christy Cassarly, Carlos A. Zarate, Lobna Ibrahim> ;Bipolar Disorders. 2012 Dec 1
• 156 citations
  Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.
  Gonzalo Laje, Níall Lally, Daniel C. Mathews, Nancy E. Brutsche, Anat Chemerinski, Nirmala Akula, Benjamin Kelmendi, Arthur A. Simen, Francis J. McMahon, Gerard Sanaco...> ;Biological Psychiatry. 2012 Dec 1
• 140 citations
  Targeting the Glutamatergic System to Treat Major Depressive Disorder
  Daniel C. Mathews, Ioline D. Henter, D. Carlos A. Zarate> ;Drugs. 2012 Jan 3
• 74 citations
  Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research ...
  Thomas J H Chen, Kenneth Blum, Daniel C. Mathews, Larry Fisher, Nancy Schnautz, Eric R. Braverman, John Schoolfield, Bernard W. Downs, David E. Comings> ;Medical Hypotheses. 2005 Jan 1
• Join now to see all